LGLFX
Price
$56.97
Change
+$0.15 (+0.26%)
Updated
Dec 3 closing price
Net Assets
7.83B
RGACX
Price
$86.23
Change
+$0.52 (+0.61%)
Updated
Dec 3 closing price
Net Assets
338.91B
Interact to see
Advertisement

LGLFX vs RGACX

Header iconLGLFX vs RGACX Comparison
Open Charts LGLFX vs RGACXBanner chart's image
Lord Abbett Growth Leaders F
Price$56.97
Change+$0.15 (+0.26%)
VolumeN/A
Net Assets7.83B
American Funds Growth Fund of Amer R3
Price$86.23
Change+$0.52 (+0.61%)
VolumeN/A
Net Assets338.91B
LGLFX vs RGACX Comparison Chart in %
View a ticker or compare two or three
VS
LGLFX vs. RGACX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LGLFX is a StrongBuy and RGACX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGACX has more cash in the bank: 339B vs. LGLFX (7.83B). RGACX pays higher dividends than LGLFX: RGACX (0.07) vs LGLFX (0.00). LGLFX was incepted earlier than RGACX: LGLFX (14 years) vs RGACX (24 years). RGACX (0.94) is less costly to investors than LGLFX (0.75). LGLFX is a more actively managed with annual turnover of: 94.00 vs. RGACX (25.00). LGLFX has a lower initial minimum investment than RGACX: LGLFX (0) vs RGACX (250). LGLFX annual gain was more profitable for investors over the last year : 15.36 vs. RGACX (6.46). LGLFX (30.35) and RGACX (29.83) have equivalent 5 years return.
LGLFXRGACXLGLFX / RGACX
Total Expense Ratio0.650.9469%
Annual Report Gross Expense Ratio0.750.9480%
Fund Existence14 years24 years-
Gain YTD17.16418.55892%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets7.83B339B2%
Annual Yield % from dividends0.000.07-
Returns for 1 year15.366.46238%
Returns for 3 years105.7860.09176%
Returns for 5 years30.3529.83102%
Returns for 10 years149.4889.90166%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NEPH5.430.20
+3.80%
Nephros
WTFCN26.34-0.03
-0.11%
Wintrust Financial Corp
HSIC71.65-1.46
-2.00%
Henry Schein
PTLO4.94-0.14
-2.76%
Portillo's
NRIX16.35-0.56
-3.31%
Nurix Therapeutics